Source: Annual Congress 2009 - Antibiotics and the lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Bilton (London, United Kingdom). Inhaled antibiotics: a new tool?. Annual Congress 2009 - Antibiotics and the lung

Member's Comments

No comment yet.

Related content which might interest you: Inhaled antibiotics: an answer to MDR pathogens? Source: International Congress 2015 – PG14 Antibiotic stewardship for respiratory infections Year: 2015 Inhaled therapies: can they breathe new life into asthma? Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now? Year: 2019 Inhaled medication: which device for which patient? Source: Eur Respir Monogr 2015; 69: 213-223 Year: 2015 Inhaled beta2-agonists in asthma management: an evolving story Source: Breathe 2016; 12: 375-377 Year: 2016 Inhaled antibiotics in critical care Source: Eur Respir Monogr 2017; 75: 80-96 Year: 2017 Inhaled corticosteroids in preschool asthmatics: are they effective and who benefits most? Source: Eur Respir J 2003; 22: Suppl. 45, 534s Year: 2003 Inhaled antibiotic therapy Source: Annual Congress 2013 –PG9 How to optimise antibiotic use in respiratory infections Year: 2013 Inhaled antibiotics: strengths and fears Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections Year: 2016 Do we need new antibiotics? Source: Annual Congress 2009 - Antibiotics and the lung Year: 2009 Spacer devices for inhaled therapy: why use them, and how? Source: ERJ Open Res, 4 (2) 00065-2018; 10.1183/23120541.00065-2018 Year: 2018 Inhaled corticosteroids in COPD: a case in favour Source: Eur Respir J 2009; 34: 10-12 Year: 2009 Inhaled corticosteroids in COPD: the clinical evidence Source: Eur Respir J 2015; 45: 525-537 Year: 2015 Emerging inhaled bronchodilators: an update Source: Eur Respir J 2009; 34: 757 Year: 2009 Inhaled antibiotics: dry or wet? Source: Eur Respir J 2014; 44: 1308-1318 Year: 2014 Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Do we have any alternative therapeutic option beyond antibiotics? Source: Postgraduate course 2021: PG7 - Postgraduate course : Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions Year: 2021 Inhaled corticosteroids in COPD: friend or foe? Source: Eur Respir J, 52 (6) 1801219; 10.1183/13993003.01219-2018 Year: 2018 Inhaled corticosteroids in COPD: the case against Source: Eur Respir J 2009; 34: 13-16 Year: 2009 Inhaled antibiotics in non-cystic fibrosis bronchiectasis: better than oral antibiotics? Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections Year: 2016